Human medicines European public assessment report (EPAR): Rapiscan, regadenoson, Date of authorisation: 06/09/2010, Revision: 17, Status: Authorised

Submitted by Anonymous (not verified) on 17 December 2025 - 13:44

Human medicines European public assessment report (EPAR): Rapiscan, regadenoson, Date of authorisation: 06/09/2010, Revision: 17, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Trixeo Aerosphere, Budesonide,Formoterol (fumarate),glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respiratory, thoraci

Submitted by Anonymous (not verified) on 17 December 2025 - 13:22

Opinion/decision on a Paediatric investigation plan (PIP): Trixeo Aerosphere, Budesonide,Formoterol (fumarate),glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: EMA/PE/0000181335

Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group

Submitted by Anonymous (not verified) on 17 December 2025 - 12:22

Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More